[Updated February 2020] The FDA is examining at the link between Belviq and cancer. On February 13, 2020, the U.S. Food and Drug Administration (FDA) asked Eisai, to voluntarily withdraw Belviq, its popular weight loss drug, from the U.S. market. The request comes on the heels of concerns between...